Investigation of the antinociceptive and anti-inflammatory properties of Heteromorpha arborescens (Apiaceae) by Nkomo, M et al.
Nkomo et al.,  Afr J Tradit Complement Altern Med. (2011) 8(4):412‐419  412
INVESTIGATION OF THE ANTINOCICEPTIVE AND ANTI-INFLAMMATORY PROPERTIES OF 
HETEROMORPHA ARBORESCENS (APIACEAE) 
 
Mpumelelo Nkomoa, Benedicta N. Nkeh-Chungagb*, Learnmore Kambizia, Eugene Jamot Ndebiac, 











                      Heteromorpha arborescens belongs to the family Apiaceae. It is commonly known as the parsley tree. One of its 
uses in the Eastern Cape Province of South Africa is for the treatment of abdominal pains. The therapeutic effects of the 
methanolic and aqueous root extracts of H. arborescens were investigated at two dose levels respectively on experimental models 
of pain and inflammation in rodents. The antinociceptive activity was evaluated using the hot-plate, abdominal constriction and 
formalin tests. The anti-inflammatory properties of these extracts were assessed using albumin and carrageenan as phlogistic 
agents. Both extracts produced significant (P<0.05, P<0.01) inhibition of thermal nociception induced by a hot plate. On chemical 
nociception induced by intraperitoneal acetic acid and subplantar formalin injection, both extracts significantly (P<0.05, P<0.01) 
decreased the number of writhing episodes and the licking time in a dose dependent manner. Treatment with the extracts at the 
same doses produced a significant (P<0.05, P<0.01) pain inhibition of the carrageenan induced inflammatory pain. Similarly, both 
extracts produced a significant (P<0.05, P<0.01) reduction of edema induced by albumin and carrageenan. These results suggest 
that both extracts of H. arborescens may act by inhibition of the mediators of inflammation. These findings seem to justify the use 
of the plant in traditional medicine in the management of pain and inflammation related diseases. 
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The management of pain and inflammation related problems is a real challenge that people face daily. Although several 
drugs are available for these conditions, medicinal plants are believed to be an important source of new chemical substances with 
potential therapeutic effects (Gupta et al., 2006). South Africa has an abundance of medicinal plants, used in the treatment of 
various diseases on an empirical basis (McGaw et al., 1997; Lin et al., 1999). Heteromorpha arborescens commonly known as the 
parsley tree in English, “wildepitersielie” in Afrikaans and “umBangandlala” in Xhosa is a medicinal plant used to treat 
abdominal pains, dysmenorrhea, nervous and mental disorders as well as a vermicide in children (Palmer and Pitman, 1973). This 
plant is found in wooded grassland, bushveld and on forest margins in South Africa. However, up to date, there is no scientific 
report or verification of the use of this plant in inflammation and pain management.  This study investigated the analgesic and the 





Materials and methods 
Plant material 
 
Roots of H. arborescens were collected in the month of August 2008 in Flagstaff (South Africa - Latitude: 29° 26' 60 S, 
Longitude: 31° 13' 60 E). The plant material was taxonomically identified by Dr Kathleen Immelman of the Kie herbarium at the 
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Walter Sisulu University and verified by the KwaZulu Natal Herbarium in Durban. A voucher specimen (Nkomo 02) was 




Root samples of H. arborescens were processed as outlined by Taylor et al. (1996) and Koduru et al. (2006). Briefly, 
the roots were chopped, air dried and pulverised. Portions of powdered plant material (50g) were shaken separately in methanol 
and water for 24 hours on an orbital shaker. The extracts were filtered using a Buchner funnel and whatman filter paper. The 
solvent from the methanol extract was evaporated using a rotor evaporator and then air-dried to yield a 17g brownish extract. On 




Two months old male and female Swiss mice (30-40 g) and Wistar rats (200-250 g) were used. The animals were 
housed in the Physiology Department animal holding facility, with a 12 hour light/dark cycle, with access to food and tap water 
ad libitum. Animals were however, deprived of food 12 hours before each experiment. The experiments reported in this study 
were carried out in accordance with current ethical guidelines for the investigation of experimental pain in conscious animals 





The writhing test was carried out as described by Gaertner et al. (1999) with slight modifications. Seven groups of mice 
(n=5/group) were treated with the aqueous extracts of H. arborescens (HAAE; 150 and 200 mg/kg), the methanolic extracts of H. 
arborescens (HAME; 150 and 200 mg/kg), Aspirin (100 mg/kg), Morphine (10 mg/kg) and control animals received an 
equivalent volume of distilled water. The writhing episodes were induced by an intraperitoneal injection of a 0.6% acetic acid 
solution (0.25 ml/animal) 30 minutes after treatment with the different drugs. The number of abdominal contortions was counted 
during the first 20 minutes after acetic acid injection. Data represents the average of the total number of abdominal contractions 
per group. 
 
Hot plate test 
 
The hot plate test was carried out as described by Wilson et al. (2005). Groups of mice (n=5) were treated with HAAE 
(150 and 200 mg/kg), HAME (150 and 200 mg/kg), Aspirin (100 mg/kg), Morphine (10 mg/kg) and distilled water. Mice were 
tested by placing them on a hot plate (Bibby Sterilin, UK) maintained at 55±1oC and the reaction time in seconds for licking of 
hind paw or jumping was recorded. The mice which reacted within 15 sec at baseline and which did not show large variation 




The formalin test was carried out as described by Santos and Calixto, (1997). Groups of mice (n=5) were treated with 
HAAE (150 and 200 mg/kg), HAME (150 and 200 mg/kg), Aspirin (100 mg/kg), Morphine (10 mg/kg) and distilled water. 
Formalin (1% v/v) was injected into the sub-plantar region of the right hind paw of the animals, one hour post treatment. The 
duration of paw licking was measured for 0–5 minutes (neurogenic phase) and 15–30 minutes (inflammatory phase) after formalin 
administration. 
 
Inflammatory pain assay 
 
The inflammatory pain assay was carried out as described by Ferreira et al. (2001) with modifications. Groups of rats 
(n=5) were treated with HAAE (150 and 200 mg/kg), HAME (150 and 200 mg/kg), Aspirin (100 mg/kg) and distilled water. Rats 
received 0.2 ml of carrageenan subcutaneously on the plantar surface of the right hind paw to induce inflammation. Pain was 
assessed using the von Frey filament (Ugo Basile, Dynamic plantar Anesthesiometer, 37450). The rats were placed on a mesh-
wire floor within individual plastic boxes, and were allowed to acclimatize for 30 minutes before the start of trials. The hairless 
plantar surface of the hind paw was probed by an electronic von Frey probe ranging from 0.01~58 g. Each monofilament was 
applied with sufficient force to bend. Responses were characterized by the brisk withdrawal or flinching of the tested paw. The 
amount of force observed indicated the mechanical pain threshold. Pain threshold was determined before the injection of 




          The albumin-induced hind paw oedema model was used in the determination of anti-inflammatory activity. This test 
was carried out as described by Okoli and Akah, (2000). Six groups of 5 rats each were allotted to different treatment groups. 
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Group 1 (control) was treated with distilled water. Groups II to V were treated orally with HAAE, (150 and 200 mg/kg), HAME 
(150 and 200 mg/kg) respectively, while group VI was treated orally with 10 mg/kg of indomethacin and used as a reference.  
Thirty minutes post treatment, oedema was induced by injection of albumin (0.1 ml, 50% v/v in saline) into sub plantar tissue of 
the right hind paw. Paw volumes were determined plethysmographically (Hugo Basile  Model No: 7140) immediately before 
injection of the phlogistic agents and at 30 minute, 1,  2  and 3 H after albumin injection. Percentage inhibition of inflammation 
(Ahmed et al. 1993; Okoli et al., 2006) was calculated using the relation: inhibition of inflammation (%) = 100 × [1- (a-x)/(b-y)], 
where a = mean paw volume of treated rats at given times after albumin injection; x = mean paw volume of treated rats before 
albumin injection; b = mean paw volume of control rats at given time after albumin injection; y = mean paw volume of control 




           The carrageenan-induced hind paw oedema model was used to confirm anti-inflammatory activity. This test was 
carried out as described by Gupta et al. (2006). Six groups of 5 rats each were allotted to different treatment groups. Animals were 
pre-treated as in the albumin-induced experiments and 30 minutes later edema was induced by the intra-plantar injection of 
carrageenan (0.1 ml, 1% w/v in saline). Paw volume measurements were made immediately before injection of the phlogistic 
agents and at 30 minutes, 1, 2 and 3 H after albumin injection using the Ugo Basile 7140 plethysmometer. Percent inhibition of 
inflammation was calculated using the relation: inhibition of edema (%) = 100 × [1- (a-x)/(b-y)], where a = mean paw volume of 
treated rats at various time after carrageenan injection; x = mean paw volume of treated rats before carrageenan injection; b = 





                  One-way analyses of variance followed by Tukey-Kramer Multiple Comparisons Test, were done to determine 
differences between control and treated groups, using the software, GraphPad Instat ® version 3.00 for Windows 95, GraphPad 








   The higher doses (200 mg/kg) of both HAAE and HAME significantly (p<0.05) inhibited acetic-acid induced 
abdominal pain while the lower doses (150 mg/kg) failed to protect against this model of pain. Morphine (10 mg/kg) and aspirin 

































































Figure 1: Antinociceptive effect of HAAE and HAME on acetic-acid induced abdominal contractions in mice.  Values represent 
the means ± SEM. (n=5) *p< 0.05; **p<0.01. 
 
Hot plate test 
 
                  The extracts of HAAE and HAME showed significant (p<0.01) analgesic properties. However, unlike morphine which 
inhibited pain significantly (p<0.01) from the 1st hour, both doses of HAME, induced a late onset (2 hour) of analgesic activity 
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and significantly increased the reaction time in treated animals. The extract of HAAE (150 mg/kg) had an even later onset of 
analgesic effect 3 H post-treatment which was also of short duration 4 H  post-treatment (Table 1).  The 200 mg/kg dose of 
HAAE showed significant analgesic activity in this pain model from 2 H post treatment and these effects remained significant 
beyond 5 H post treatment. 
 
Table 1: Effect of HAAE and HAME on reaction time to pain induced by a hot plate 
   Time difference (s) 
 Dose  1h 2h 3h 4h 5h  
Control   1.20 1.00 - 0.60 - 0.20 - 1.20  
HAAE 150 mg/kg  4.25 4.00 6.80** 8.20** 3.40  
HAAE 200 mg/kg  4.40 9.20** 14.40** 12.20** 11.20**  
HAME 150 mg/kg  4.48 7.80** 9.20** 10.40** 6.60**  
HAME 200 mg/kg  5.80 9.20** 14.40** 12.00** 11.40**  
Morphine 10 mg/kg  6.20** 7.20** 7.40** 5.60* 8.00  
 
Results expressed in this table are the differences between reaction time at given time and the reaction time at baseline. Values are 




The formalin test exhibited the characteristic biphasic response. Phase 1 response which was recorded from the time of 
formalin injection and 5 minutes post-injection was not affected by either extract at either dose level. Morphine however, showed 
significant (p<0.05) inhibition of pain in this phase (Fig 2). The second phase of the response was noted from 10 minutes to 30 
minutes post formalin injection. The extracts of HAAE (150 mg/kg and 200 mg/kg) and HAME (150 mg/kg and 200 mg/kg) as 
well as aspirin and morphine showed significant (p<0.01) inhibition of formalin-induced pain (Fig 2). The extract of HAME 150 
mg/kg significantly inhibited inflammatory pain compared to 200 mg/kg HAAE. 

















































































































Figure 2. Antinociceptive effect of the extracts of HAAE and HAME in inhibiting formalin-induced pain. Values represent the 
means ± SEM. (n=5) **p<0.01.  
 
Inflammatory pain assay 
 
As shown in Figure 3, the administration of both HAAE and HAME significantly (P<0.05, P<0.01) increased the paw 
withdrawal latencies in mechanical hyperalgesia induced by carrageenan from 1 to 4 H. The analgesic effect of both extracts on 
inflammatory pain was comparable to that of indomethacin (10 mg/kg) a standard anti-inflammatory drug. 
At the end of the 24 H post treatment, only the 200 mg/kg HAAE extract continued to show significant analgesic effects in this 
pain model (Fig 3).  
doi: 10.4314/ajtcam.v8i4.11
Nkomo et al.,  Afr J Tradit Complement Altern Med. (2011) 8(4):412‐419  416
 
Figure 3: Antinociceptive effect of HAAE and HAME extracts on inflammatory pain induced by carrageenan. Values represent 
the means ± SEM. n=5; *p<0.05; **p < 0.01, Indo: Indomethacin. 
 
 
Albumin induced inflammation 
 
The anti-inflammatory activities of HAAE and HAME on albumin-induced inflammation are summarized in Table 2. 
The 150 mg/kg HAAE extract had significant (p<0.05 and p<0.01) analgesic properties from 1 to 3 hours post treatment though 
the 200 mg/kg failed to produce similar anti-inflammatory effects. With the HAME extract, significant anti-inflammatory 
properties were noted though the 150 mg/kg extract tended to have better anti-inflammatory properties than the 200 mg/kg dose. 




Table 2: Effect of extracts of HAAE and HAME on albumin-induced inflammation in the rat hind paw 
 Inhibition of Inflammation (%) 
 Dose 1h 2h 3h 
Control - - - - 
HAAE 150 mg/kg 57.8** 37.4* 44.4* 
HAAE 200 mg/kg 26.7 24.8 32.1 
HAME 150 mg/kg 66.9** 56.3* 73.5* 
HAME 200 mg/kg 65.5** 53.4* 65.4* 
Indo 100 mg/kg 67.9** 59.7* 59.3* 
 





Both HAAE and HAME showed significant analgesic effects against carrageenan-induced inflammation. The lower 
doses (150 mg/kg) of HAAE and HAME had a later onset (2 H) while the higher dose of HAAE showed anti-inflammatory 
effects which were of an earlier onset and persisted after 3 H (Table 3). Unlike the extract indomethacin showed a later onset of 
anti-inflammatory properties which was significant from 3 hours post treatment.  
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Table 3: Effect of HAAE and HAME on carrageenan induced inflammation in the rat paw 
 Inhibition of Inflammation (%) 
 Dose 1h 2h 3h 
control - - - - 
HAAE 150 mg/kg 59 68** 50* 
HAAE 200 mg/kg 57* 65** 71** 
HAME 150 mg/kg 53 71** 67** 
HAME 200 mg/kg 75 73** 72** 
Indo 100 mg/kg 39 36 59** 
 







The present study investigated the antinociceptive and the anti-inflammatory properties of the aqueous and methanolic 
extracts of roots of H. arborescens using various animal models. The plant extracts showed anti-nociceptive and analgesic 
properties thus providing proof of the efficacy of this plant in its use by the Xhosa people for the treatment of pain and 
inflammation. 
The acetic acid-induced abdominal writhing method showed that at the higher dose levels, both HAAE and HAME had 
analgesic properties which were comparable with those of aspirin a peripherally acting analgesic. Acetic acid induces pain by the 
release of endogenous mediators of pain such as prostaglandin through the activity of cyclooxygenase (COX) (Satyanarayana et 
al., 2004; Ballou et al., 2000). Therefore this model of pain should be inhibited by peripheral analgesics through the inhibition of 
COX activity. Our results therefore show that the higher doses of HAAE and HAME have peripheral analgesic properties similar 
to aspirin by inhibition of the release of endogenous pain mediators. The acetic acid-induced abdominal contraction test is 
essentially a screening test for analgesic properties and not specific in its response, other more specific tests were performed to 
confirm the observed results. 
The hot-plate test was utilized to assess the central antinociceptive properties of HAAE and HAME. This test is 
sensitive to drugs which exert their analgesic effects through the CNS. The two doses of HAME like 200 mg/kg of HAAE showed 
significantly increased reaction time to thermal stimulation from 2 hours to beyond 5 hours post treatment. This was not the case 
with 150 mg/kg of HAAE which showed analgesic effects from 3 hours to 4 hours post treatment probably because the amount of 
active principle in it is smaller compared to the higher dose. Morphine a central acting analgesic increased the reaction time from 
1 hour post treatment. Since HAAE and HAME were able to increase the latency to thermal stimulation, they could therefore have 
some central analgesic properties. In order to further confirm the analgesic properties of these extracts, the formalin test was 
carried out. 
The formalin test is said to be a model of pain which closely resembles clinical pain compared to the other nociceptive 
models (Tjolsen and Hole, 1997). This test has two distinct phases: the first phase (neurogenic pain) due to direct chemical 
stimulation of nociceptors, results from the stimulation of myelinated and unmyelinated nociceptive afferent fibers, mainly C 
fibers, which can be suppressed by opioid analgesic drugs like morphine (Sayyah et al., 2004). The second or late phase seems to 
be an inflammatory response which elicits inflammatory pain and can be inhibited by anti-inflammatory drugs (Young at al., 
2005). The second phase is caused by the release of inflammatory mediators such as prostaglandins and histamine in the 
peripheral tissues, as well as functional changes in the neurons, of the spinal cord which may facilitate transmission in the spinal 
cord (Franca et al., 2001; Garcia et al., 2004). Both HAAE and HAME failed to have an effect on the neurogenic phase of the 
formalin test. However, in the inflammatory phase both extracts showed significant inhibition of pain. The HAME extracts 
showed significant inhibition of formalin induced-pain which was more profound than results obtained with HAAE. The observed 
effects with 150 mg/kg HAME was significantly different from results obtained with HAAE. These extracts showed analgesic 
properties against inflammatory pain thus suggesting that it might be acting by inhibiting the release of inflammatory mediators in 
the injected paw while failing to block the transmission of pain via C fibres. To further elucidate the effects of these extracts on 
the late phase of the formalin test, we therefore, investigated the effects of HAAE and HAME on a model of inflammatory pain 
induced by carrageenan.  
The extracts of HAAE and HAME inhibited carrageenan-induced hyperalgesia 2 and 4 hours after treatment. Unlike 
HAME whose effects were observed only during the second and fourth hours post-treatment, HAAE had anti-hyperalgesic effects 
which were still significant 24 hours post-treatment. This anti-hyperalgesic effect of extracts of H. arborescens corroborates the 
result obtained from the late phase of formalin test suggesting a possible anti-inflammatory response. These observations suggest 
that H. arborescens may act by decreasing the production of mediators of inflammation. For further investigation, the effect of 
HAAE and HAME were evaluated against inflammation induced by fresh egg albumin and carrageenan. 
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Extracts of both HAAE and HAME inhibited both phases of the carrageenan-induced inflammatory process indicating that the 
extracts have effects on both the early release of histamine and serotonin as well as the late phase involving the inhibition of 
cycloocygenase. Indomethacin and the other NSAIDs inhibit the second phase of this inflammatory process. Carrageenan-induced 
oedema has been commonly used as an experimental model for acute inflammation and is believed to be biphasic (Posadas et al, 
2004). The early phase (1 - 2 hours) of the carrageenan model is mainly mediated by histamine and serotonin released in the 
damaged tissue surroundings (Badilla 2003). The late phase is sustained by prostaglandin release and mediated by bradykinin, 
leukotrienes, polymorphonuclear cells and prostaglandins produced by tissue macrophages (Gupta et al., 2006; Brito and Antonio, 
1998). The inhibitory activity shown by both extracts of H. arborescens mostly after the second hour may indicate that the extract 
acts in the early phase probably involving neutrophils mobilization (Gupta et al., 2006; Just et al., 1998). 
Based on the results of this study, it can be concluded that the aqueous and methanolic extracts of H. arborescens 
possess analgesic and anti-inflammatory properties. These findings justify the use of the plant in traditional medicine in the 





This work was supported by the Walter Sisulu University Institutional Research fund and the Nation Research 






1. Ahmed, M.M., Qureshi, S., Al-bekairi, A.M., Shah, A.H. and  Rao, R.M. (1993). Antiinflammatory activity of Caralluma 
tuberculata alcoholic extract. Fitoterapia. 64:359-362. 
2. Badilla B, Arias AY, Arias M, Mora GA and Poveda LJ. (2003). Anti-inflammatory and antinociceptive activities of Loasa 
speciosa in rats and mice. Fitoterapia. 74:45 - 51  
3. Ballou E.R., Botting R.M., Goorha S., Zhanag J. and Vane J.R. (2000). Nociception in cyclooxygenase isozyme deficient 
mice. PNAS. 97:10272-10276. 
4. Brito, A. R. M. S. and Antonio, M. A. (1998). Oral antiinflammatory and antiulcerogenic activities of a hydroalcoholic extract 
and partitioned fractions of Turnera ulmifolia (Turneraceae). Journal of Ethnopharmacology. 61:215-228. 
5. Ferreira J., Campos M. M., Pesquero, J. B., Araújo R. C., Bader M. and Calixto J. B. (2001). Evidence for the participation of 
kinins in Freund's adjuvant-induced inflammatory and nociceptive responses in kinin B1 and B2 receptor knockout mice. 
Neuropharmacology. 41 :1006–1012. 
6. Franca, D. S., Souza, A. L. S., Almeida, K. R., Dolabella, S. S., Martinelli, C. and Coelho, M. M. (2001). B vitamins induce 
an antinociceptive effect in the acetic acid and formaldehyde models of nociception in mice.European Journal of 
Pharmacology. 421 :157–164. 
7. Gaertner M., Muller, L., Roos, J.F., Cani, G., Santos, A.R.S., Niero, R., Calixto, J.F., Yunes, R.A., Delle Monache, F. and 
Cechinel-Fehho, V. (1999). Analgesic triterpenes from Sebastiania schottianan roots. Phytomedicine.  6:41–44. 
8. Garcıa, M. D., Fernandez, M. A., Alvarez, A. and Saenz, M. T. (2004).  Antinociceptive and anti-inflammatory effect of the 
aqueous extract from leaves of Pimenta racemosa var. ozua (Mirtaceae). Journal of Ethnopharmacology  91: 69-73. 
9. Gupta M., Mazumder1 U. K., Gomathi P. and Thamil S. V. (2006) Antiinflammatory evaluation of leaves of Plumeria 
acuminata. BMC Complementary and Alternative Medicine; 6:36. 
10. Just, M. J., Recio, M. C., Giner, R. M., Cullar, M. J., Manez, S. and Bilia, A.R. (1998). Antiinflammatory activity of 
unusual Lupane saponins from Bupleurum fruticescens.  Planta Medica.  64:404 - 407. 
11. Koduru S., Grierson D. S. and Afolayan A.J. (2006) Antimicrobial activity of Solanum aculeastrum. Pharmaceutical 
Biology. 44: 283 – 286. 
12. Lin, J., Opoku, A. R.,  Geheem-Keller ,M., Hutchings, A. D., Terblanche, S. E., Jäger, A. K. and Van Staden, J. (1999). 
Preliminary screening of some Zulu medicinal plants for anti-inflammatory and anti-microbial activities.  Journal of 
Ethnopharmacology. 68: 267 – 274. 
13. McGaw, L.J., Jäger, A.K. and van Staden, J. (1997). Prostaglandin synthesis inhibitory activity in Zulu, Xhosa and 
Sotho medicinal plants. Phytotherapy Research. 11: 113 -117.  
14. Okoli, C.O. and Akah, P.A. (2000). A pilot evaluation of the anti-inflammatory activity of Culcasia scandens, a 
traditional antirheumatic agent. Journal of Alternative and Complementary Medicine.  6:423–427. 
15. Okoli, C.O., Akah, P.A., Nwafor, S.V., Anisiobi, A.I., Ibegbunam, I.N. and  Erojikwe, O. (2006). Anti-inflammatory 
activity of hexane leaf extract of Aspilia africana C.D. Adams. Journal of Ethnopharmacology. 109: 219–225. 
16. Palmer, E. and Pitman, N. (1973). Trees of Southern Africa. Balkema, Cape Town.  
17. Posadas I, Bucci M, Roviezzo F, Rossi A, Parente L, Sautebin L and Cirino G. (2004). Carrageenan-induced mouse paw 
oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression. British Journal 
of Pharmacology. 142: 331–338. 
doi: 10.4314/ajtcam.v8i4.11
Nkomo et al.,  Afr J Tradit Complement Altern Med. (2011) 8(4):412‐419  419
18. Santos, A.R. and Calixto, J.B. (1997).  Further evidence for the involvement of tachykinin receptor subtypes in formalin 
and capsaicin models of pain in mice. Neuropeptides.  31: 381–389. 
19. Satyanarayana P.S.V., Jain N.K., Singh S. and Kulkarni S.K. (2004).  Effect of selective inhibition of cyclooxygenase-2 
on lipopolysaccharideinduced hyperalgesia. Inflammopharmacology. 12: 57-68. 
20. Sayyah, M., Hadidi, N. and Kamalinejad, M. (2004). Analgesic and anti-inflammatory activity of Lactuca sativa seed 
extract in rats. Journal of Ethnopharmacology.  92:325–329. 
21. Taylor R. S. L., Edel F., Manandhar N. P. and Towers G. H. N. (1996). Antimicrobial activity of southern Nepalese 
medicinal plants. J.Ethnopharmacology 50: 97 – 102.  
22. Tjolsen, A. and Hole, K. (1997).  Animal models of analgesia. In: The Pharmacology of Pain, v. 130. Verlag, Berlin.  
pp.: 1–20. 
23. Wilson, S.G., Bryant, C.D., Lariviere, W.R., Olsen, M.S., Giles, B.E., Chesler, E.J., Young, H., Luo,Y., Cheng, H., 
Hsieh,W., Liao, J. and Peng,W. (2005). Analgesic and anti-inflammatory activities of [6]-gingerol. Journal of 
Ethnopharmacology.  96, 207–210. 
24. Young, H., Luo,Y., Cheng, H., Hsieh,W., Liao, J. and Peng,W. (2005).  Analgesic and anti-inflammatory activities of 
[6]-gingerol. Journal of Ethnopharmacology.   96:207–210. 
25. Zimmermann, M. Ethical guidelines for investigations of experimental pain in conscious animals. (1983) Pain. 16: 109–
110. 
 
 
doi: 10.4314/ajtcam.v8i4.11
